Cargando…
Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms
The evolutionary response to endemic infections with parasitic worms (helminth) was the development of a distinct regulatory immune profile arising from the need to encapsulate the helminths while simultaneously repairing tissue damage. According to the old friend’s hypothesis, the diminished exposu...
Autores principales: | Dixit, Aakanksha, Tanaka, Akane, Greer, Judith M., Donnelly, Sheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666823/ https://www.ncbi.nlm.nih.gov/pubmed/29027962 http://dx.doi.org/10.3390/ijms18102141 |
Ejemplares similares
-
A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis
por: Lund, Maria E., et al.
Publicado: (2016) -
How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk
por: Camaya, Inah, et al.
Publicado: (2023) -
Parasitic worms and inflammatory diseases
por: ZACCONE, P, et al.
Publicado: (2006) -
Novel Insights and Therapeutics in Multiple Sclerosis
por: Wagner, Catriona A., et al.
Publicado: (2015) -
Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis
por: Greer, Judith M.
Publicado: (2013)